Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Baird analyst Eric Coldwell upgraded the rating for McKesson Corporation (NYSE:MCK) from Neutral to Outperform and raised the price target from $531 to $688. McKesson shares closed at $549.31 on Wednesday. See how other analysts view this stock.
• Raymond James analyst Ric Prentiss upgraded United States Cellular Corporation (NYSE:USM) from Market Perform to Outperform and announced a price target of $86. United States Cellular shares closed at $65.15 on Wednesday. See how other analysts view this stock.
• Cantor Fitzgerald analyst Kristen Kluska upgraded the rating for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Neutral to Overweight and boosted the price target from $152 to $167. Sarepta Therapeutics shares closed at $127.97 on Wednesday. See how other analysts view this stock.
• JP Morgan analyst Alexei Gogolev upgraded Clearwater Analytics Holdings, Inc. (NYSE:CWAN) from Neutral to Overweight and raised the price target from $23 to $33. Clearwater Analytics shares closed at $28.58 on Wednesday. See how other analysts view this stock.
• Wells Fargo analyst Steven Cahall upgraded the rating for Sinclair, Inc. (NASDAQ:SBGI) from Underweight to Equal-Weight and increased the price target from $13 to $19. Sinclair shares closed at $17.41 on Wednesday. See how other analysts view this stock.

Considering buying MCK stock? Here's what analysts think:

Read This Next:

• Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom